Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls.

Schuurhof A, Bont L, Siezen CL, Hodemaekers H, van Houwelingen HC, Kimman TG, Hoebee B, Kimpen JL, Janssen R.

Pediatr Pulmonol. 2010 Jun;45(6):608-13. doi: 10.1002/ppul.21229.

PMID:
20503287
2.

Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology.

Kimman TG, Cornelissen LA, Moormann RJ, Rebel JM, Stockhofe-Zurwieden N.

Vaccine. 2009 Jun 8;27(28):3704-18. doi: 10.1016/j.vaccine.2009.04.022. Epub 2009 May 3. Review.

PMID:
19464553
3.

Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes.

Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van't Slot R, Wijmenga C, Houwelingen HC, Kimpen JL, Kimman TG, Hoebee B, Janssen R.

Pediatr Infect Dis J. 2009 Apr;28(4):333-5. doi: 10.1097/INF.0b013e31818e2aa9.

PMID:
19258923
4.

Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination.

Kimman TG, Banus S, Reijmerink N, Reimerink J, Stelma FF, Koppelman GH, Thijs C, Postma DS, Kerkhof M.

PLoS One. 2008;3(11):e3665. doi: 10.1371/journal.pone.0003665. Epub 2008 Nov 6.

5.

Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Kimman TG, Smit E, Klein MR.

Clin Microbiol Rev. 2008 Jul;21(3):403-25. doi: 10.1128/CMR.00014-08. Review.

6.

Identification of a common gene expression response in different lung inflammatory diseases in rodents and macaques.

Pennings JL, Kimman TG, Janssen R.

PLoS One. 2008 Jul 9;3(7):e2596. doi: 10.1371/journal.pone.0002596.

7.

The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.

Banus S, Stenger RM, Gremmer ER, Dormans JA, Mooi FR, Kimman TG, Vandebriel RJ.

BMC Immunol. 2008 May 22;9:21. doi: 10.1186/1471-2172-9-21.

8.

Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly.

Buisman AM, Abbink F, Schepp RM, Sonsma JA, Herremans T, Kimman TG.

J Infect Dis. 2008 Mar 1;197(5):698-706. doi: 10.1086/527487.

PMID:
18279050
9.

Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract.

van Elden LJ, Sachs AP, van Loon AM, Haarman M, van de Vijver DA, Kimman TG, Zuithoff P, Schipper PJ, Verheij TJ, Nijhuis M.

J Clin Virol. 2008 Feb;41(2):116-21. Epub 2007 Dec 21.

PMID:
18096430
10.

Comparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection.

Banus S, Vandebriel RJ, Pennings JL, Gremmer ER, Wester PW, van Kranen HJ, Breit TM, Demant P, Mooi FR, Hoebee B, Kimman TG.

BMC Microbiol. 2007 Oct 12;7:88.

11.

Genetic variation in the response to vaccination.

Kimman TG, Vandebriel RJ, Hoebee B.

Community Genet. 2007;10(4):201-17. Review.

PMID:
17895626
12.

Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.

Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, Doornbos G, van 't Slot R, Wijmenga C, Goeman JJ, Kimpen JL, van Houwelingen HC, Kimman TG, Hoebee B.

J Infect Dis. 2007 Sep 15;196(6):826-34. Epub 2007 Aug 10.

PMID:
17703412
13.

Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study.

Banus S, Bottema RW, Siezen CL, Vandebriel RJ, Reimerink J, Mommers M, Koppelman GH, Hoebee B, Thijs C, Postma DS, Kimman TG, Stelma FF.

Clin Vaccine Immunol. 2007 Oct;14(10):1377-80. Epub 2007 Aug 15.

14.

Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.

Boot HJ, Wallenburg I, de Melker HE, Mangen MJ, Gerritsen AA, van der Maas NA, Berkhof J, Meijer CJ, Kimman TG.

Vaccine. 2007 Aug 14;25(33):6245-56. Epub 2007 Jun 21.

PMID:
17630049
15.

Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people.

Boot HJ, Sonsma J, van Nunen F, Abbink F, Kimman TG, Buisman AM.

Vaccine. 2007 Jun 11;25(24):4706-14. Epub 2007 Apr 20.

PMID:
17482726
16.

Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells.

Boogaard I, van Oosten M, van Rijt LS, Muskens F, Kimman TG, Lambrecht BN, Buisman AM.

Immunology. 2007 Sep;122(1):65-72. Epub 2007 Apr 30.

17.

[Effect of genetic polymorphisms on the susceptibility to and course of infectious diseases].

Kimman TG, Janssen R, Hoebee B.

Ned Tijdschr Geneeskd. 2007 Mar 3;151(9):519-24. Review. Dutch.

PMID:
17373392
18.

IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection.

Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, Bont L.

J Allergy Clin Immunol. 2007 May;119(5):1086-91. Epub 2007 Feb 20.

PMID:
17313976
19.

[Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme].

Boot HJ, Schouls L, Hahné S, Berbers GA, van de Laar M, Kimman TG.

Ned Tijdschr Geneeskd. 2007 Jan 20;151(3):172-6. Review. Dutch.

PMID:
17288341
20.

Preclinical and clinical safety studies on DNA vaccines.

Schalk JA, Mooi FR, Berbers GA, van Aerts LA, Ovelgönne H, Kimman TG.

Hum Vaccin. 2006 Mar-Apr;2(2):45-53. Epub 2006 Mar 16. Review.

PMID:
17012886
21.
22.

Identification, phenotypic analysis, and full-length nucleotide sequence of a Dutch Coxsackievirus A20 isolate.

Boot HJ, Lukashov VV, van Remmerden Y, Kimman TG.

Virus Genes. 2007 Jan;34(1):75-85. Epub 2006 Sep 9.

PMID:
16964555
23.

Assessing the introduction of universal varicella vaccination in the Netherlands.

Boot HJ, de Melker HE, Stolk EA, de Wit GA, Kimman TG.

Vaccine. 2006 Sep 11;24(37-39):6288-99. Epub 2006 Jun 8.

PMID:
16790302
24.

Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.

Banus HA, Vandebriel RJ, de Ruiter H, Dormans JA, Nagelkerke NJ, Mooi FR, Hoebee B, van Kranen HJ, Kimman TG.

Infect Immun. 2006 May;74(5):2596-605.

25.

Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.

Kimman TG, Boot HJ, Berbers GA, Vermeer-de Bondt PE, Ardine de Wit G, de Melker HE.

Vaccine. 2006 May 29;24(22):4769-78. Epub 2006 Mar 27.

PMID:
16616803
26.

Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.

Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA.

J Infect Dis. 2005 Mar 15;191(6):990-9. Epub 2005 Feb 10.

PMID:
15717277
27.

Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice.

Banus HA, van Kranen HJ, Mooi FR, Hoebee B, Nagelkerke NJ, Demant P, Kimman TG.

Infect Immun. 2005 Feb;73(2):741-7.

28.

[Protection of children born to hepatitis-B-infected mothers].

Boot HJ, Vermeer-de Bondt PE, Kimman TG.

Ned Tijdschr Geneeskd. 2004 Sep 11;148(37):1816-8. Review. Dutch.

PMID:
15495509
29.

Combining the transmission disequilibrium test and case-control methodology using generalized logistic regression.

Nagelkerke NJ, Hoebee B, Teunis P, Kimman TG.

Eur J Hum Genet. 2004 Nov;12(11):964-70.

30.

Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.

Barends M, Van Oosten M, De Rond CG, Dormans JA, Osterhaus AD, Neijens HJ, Kimman TG.

J Infect Dis. 2004 May 15;189(10):1866-72. Epub 2004 Apr 27.

PMID:
15122523
31.

Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice.

Barends M, de Rond LG, Dormans J, van Oosten M, Boelen A, Neijens HJ, Osterhaus AD, Kimman TG.

Clin Exp Allergy. 2004 Mar;34(3):488-96.

PMID:
15005745
32.

Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis.

Hoebee B, Bont L, Rietveld E, van Oosten M, Hodemaekers HM, Nagelkerke NJ, Neijens HJ, Kimpen JL, Kimman TG.

J Infect Dis. 2004 Jan 15;189(2):239-47. Epub 2004 Jan 9.

PMID:
14722888
33.
34.

Pathogenesis of poliovirus infection in PVRTg mice: poliovirus replicates in peritoneal macrophages.

Buisman AM, Sonsma JA, van Wijk MG, Vermeulen JP, Roholl PJ, Kimman TG.

J Gen Virol. 2003 Oct;84(Pt 10):2819-28.

PMID:
13679616
35.

Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands.

van Binnendijk RS, van den Hof S, van den Kerkhof H, Kohl RH, Woonink F, Berbers GA, Conyn-van Spaendonck MA, Kimman TG.

J Infect Dis. 2003 Sep 15;188(6):898-903. Epub 2003 Aug 25.

PMID:
12964122
36.
37.

Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms.

Hoebee B, Rietveld E, Bont L, Oosten Mv, Hodemaekers HM, Nagelkerke NJ, Neijens HJ, Kimpen JL, Kimman TG.

J Infect Dis. 2003 Jan 1;187(1):2-11. Epub 2002 Dec 13.

PMID:
12508140
38.

Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma.

Barends M, Boelen A, de Rond L, Dormans J, Kwakkel J, van Oosten M, Neijens HJ, Kimman TG.

J Med Virol. 2003 Jan;69(1):156-62.

PMID:
12436492
39.

Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.

Herremans T, Kimman TG, Conyn-Van Spaendonck MA, Buisman A, de Melker H, Abbink F, Bijkerk P, Koopmans MP.

Clin Infect Dis. 2002 Apr 15;34(8):1067-75. Epub 2002 Mar 20.

PMID:
11914995
40.

Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors.

Van Loveren H, Van Amsterdam JG, Vandebriel RJ, Kimman TG, Rümke HC, Steerenberg PS, Vos JG.

Environ Health Perspect. 2001 Aug;109(8):757-64. Review.

41.

Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy.

de Jong JC, Heinen PP, Loeffen WL, van Nieuwstadt AP, Claas EC, Bestebroer TM, Bijlsma K, Verweij C, Osterhaus AD, Rimmelzwaan GF, Fouchier RA, Kimman TG.

Vaccine. 2001 Aug 14;19(31):4452-64.

PMID:
11483271
42.

An analysis of a presumed major outbreak of pseudorabies virus in a vaccinated sow herd.

Van Nes A, De Jong MC, Kersten AJ, Kimman TG, Verheijden JH.

Epidemiol Infect. 2001 Feb;126(1):119-28.

43.
44.

Immunity to poliomyelitis in The Netherlands.

Conyn-Van Spaendonck MA, de Melker HE, Abbink F, Elzinga-Gholizadea N, Kimman TG, van Loon T.

Am J Epidemiol. 2001 Feb 1;153(3):207-14.

PMID:
11157405
45.

Discrimination of different subsets of cytolytic cells in pseudorabies virus-immune and naive pigs.

de Bruin TG, van Rooij EM, de Visser YE, Voermans JJ, Samsom JN, Kimman TG, Bianchi AT.

J Gen Virol. 2000 Jun;81(Pt 6):1529-37.

PMID:
10811936
47.
48.

Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.

Herremans TM, Reimerink JH, Buisman AM, Kimman TG, Koopmans MP.

J Immunol. 1999 Apr 15;162(8):5011-8.

49.

Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy.

de Jong JC, van Nieuwstadt AP, Kimman TG, Loeffen WL, Bestebroer TM, Bijlsma K, Verweij C, Osterhaus AD, Class EC.

Vaccine. 1999 Mar 17;17(11-12):1321-8.

PMID:
10195767
50.

Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D.

Haagmans BL, van Rooij EM, Dubelaar M, Kimman TG, Horzinek MC, Schijns VE, Bianchi AT.

Vaccine. 1999 Mar 5;17(9-10):1264-71.

PMID:
10195639

Supplemental Content

Loading ...
Support Center